Journey Medical Corporation's Financial Results Release
Journey Medical Corporation (NASDAQ: DERM), a prominent pharmaceutical company dedicated to dermatological treatments, is making headlines with its upcoming announcement of third quarter financial results. This announcement is eagerly awaited by investors and stakeholders alike. The financial report will be disclosed following the closure of U.S. financial markets on Wednesday, November 12, 2025.
What to Expect in the Conference Call
Later that same day, Journey Medical's management will host a conference call at 4:30 p.m. ET. This call presents an excellent opportunity for analysts, investors, and all interested parties to gain insights directly from the company's leadership. It is highly recommended for participants to dial in approximately ten minutes prior to the scheduled start time to ensure they can join the call without interruption.
Dial-in Details for Participants
For those in the U.S., the dial-in number is 1-866-777-2509, while international participants can call 1-412-317-5413. Preparing for this call in advance will enhance the experience as attendees can listen to the management discuss the quarterly performance and address questions from the audience.
Webcast Availability
Alongside the phone call, a live audio webcast will also be accessible through the Investors section of Journey Medical’s website. This provides a convenient option for those who prefer an online format. The session will be available for replay for around 30 days, ensuring that anyone who misses the live event can still catch up.
About Journey Medical Corporation
Journey Medical Corporation is a commercial-stage pharmaceutical entity focused on marketing FDA-approved prescription products for dermatological issues. Currently, the company boasts eight branded medications aimed at tackling various skin conditions. Their team comprises experienced professionals with proven success in developing and launching effective dermatology pharmaceuticals.
The Company's Commitment to Dermatology
In the realm of skincare and treatment developments, Journey Medical's innovative practices position them as leaders. They aim to improve the quality of life for individuals with skin disorders by providing accessible and effective solutions. Their unique sales and marketing strategies have led to the successful commercialization of their products.
Company Overview and Contacts
Founded by Fortress Biotech, Inc. (NASDAQ: FBIO), Journey Medical operates out of Scottsdale, Arizona, adhering to strict securities regulations as registered under the Securities Exchange Act of 1934. They file regular reports with the U.S. Securities and Exchange Commission (SEC), furthering their commitment to transparency.
Contact Information
For further inquiries, Jaclyn Jaffe at Journey Medical Corporation can be reached at (781) 652-4500 or via email at ir@jmcderm.com. Additionally, media relations can be handled through Tony Plohoros at 6 Degrees, reachable at (908) 591-2839 or tplohoros@6degreespr.com.
Frequently Asked Questions
When will Journey Medical announce their Q3 financial results?
The announcement is scheduled for November 12, 2025, after the market closes.
How can investors participate in the conference call?
Investors can dial 1-866-777-2509 for domestic calls and 1-412-317-5413 for international calls, starting 10 minutes before 4:30 p.m. ET on the same day.
Is there a way to access a recording of the conference call?
Yes, the audio webcast will be available on Journey Medical's website for approximately 30 days after the call.
What specific area does Journey Medical specialize in?
They specialize in marketing and selling prescription products for the treatment of dermatological conditions.
Who founded Journey Medical Corporation?
Journey Medical was founded by Fortress Biotech, Inc.
